Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab in Neo Wild-Type Metastatic Colorectal Cancer
NCT04189055Phase 2Unknown
- Sponsor
- Hôpital Franco-Britannique - Fondation Cognacq-Jay
- Start
- Jan 2020
- Primary completion
- Apr 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in metastatic colorectal cancer (mCRC), sponsored by Hôpital Franco-Britannique - Fondation Cognacq-Jay. Status: unknown.
02
Drugs
KL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT04189055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189055.